Spondyloarthritis (SpA) is a group of disorders characterized by inflammatory arthritis including ankylosing spondylitis, psoriatic arthritis, reactive arthritis and arthritis-related inflammatory bowel diseases. Recently it has been shown that arthritic disorders are accompanied by olfactory dysfunction. We aimed to specifically investigate the association between spondyloarthritis and olfactory impairment.
Materials and methods
Fifty individuals with SpA and 50 healthy volunteers were included in the study. Olfactory function was evaluated using the “Sniffin’ Sticks” test battery. Additionally, effects of age, gender, activity of the disease, HLA-B27 status, medications, and the duration of disease were included in the analysis.
SpA patients showed significantly lower scores for odor threshold (T), odor discrimination (D) and odor identification (I) than healthy controls (all p < 0.001). In addition, olfactory loss was negatively correlated with the presence of HLA-B27 (Human Leukocyte Antigen), but not with the current activity of the disease (Bath Ankylosing Spondylitis Activity Index). Neither medication nor duration of the disease had a significant effect on the results.
SpA is associated with olfactory loss. Future studies will show whether olfactory function relates to the prognosis of SpA.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Akgul O, Ozgocmen S (2011) Classification criteria for spondyloarthropathies. World J Orthop 2:107–115
Thomas G, Brown M (2010) Genetics and genomics of ankylosing spondylitis. Immunol Rev 233:162–180
Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL et al (1997) Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40:1823–1828
Sieper J, Braun J, Kingsley GH (2000) Report on the fourth international workshop on reactive arthritis. Arthritis Rheum 43:720–8
Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61(Suppl III):iii8–iiii13
Liao Z, Gu J, Huang F, Lin Z, Zhao L, Yu B (2009) Verification of Berlin algorithm for diagnosing undifferentiated spondyloarthropathy patients in Chinese population. Jt Bone Spine 76:146–149
Tekeli H, Senol MG, Altundag A, Yalcinkaya E, Kendirli MT, Yasar H et al (2015) Olfactory and gustatory dysfunction in myasthenia gravis: a study in Turkish patients. J Neurol Sci 356(1–2):188–192
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT et al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25–31
Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264(3):237–243
Haehner A, Mayer AM, Landis BN, Pournaras I, Lill K, Gudziol V et al (2009) High test–retest reliability of the extended version of the “Sniffin’ Sticks” test. Chem Senses 34(8):705–711
Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM et al (2017) Position paper on olfactory dysfunction. Rhinol Suppl 54 26:1–30
Brämerson A, Johansson L, Ek L, Nordin S, Bende M (2004) Prevalence of olfactory dysfunction: The Skövde population-based study. Laryngoscope 114:733–737
Reveille JD (2012) Genetics of spondyloarthritis, beyond the MHC. Nat Rev Rheumatol 8:296–304
Robinson PC, Brown MA (2012) The genetics of ankylosing spondylitis and axial spondyloarthritis. Rheum Dis Clin N Am 38:539–553
DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA (2009) HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 60:2633–2639
Steinbach S, Proft F, Schulze-Koops H, Hundt W, Heinrich P, Schulz S et al (2011) Gustatory and olfactory function in rheumatoid arthritis. Scand J Rheumatol 40:169–177
Shoenfeld N, Agmon-Levin N, Flitman-Katzevman I, Paran D, Katz BS, Kivity S et al (2009) The sense of smell in systemic lupus erythematosus. Arthritis Rheum 60:1484–1487
Tekeli H, Altundag A, Salihoglu M, Cayonu M, Kendirli MT (2013) The applicability of the “Sniffin’ Sticks” olfactory test in a Turkish population. Med Sci Monit 19:1221–1223
Proft F, Steinbach S, Dechant C, Witt M, Reindl C, Schulz S et al (2014) Gustatory and olfactory function in patients with granulomatosis with polyangiitis (Wegener’s). Scand J Rheumatol 43:512–518
Midilli R, Gode S, Oder G, Kabasakal Y, Karci B (2013) Nasal and paranasal involvement in primary Sjogren’s syndrome. Rhinology 51:265–267
Perricone C, Shoenfeld N, Agmon-Levin N, de Carolis C, Perricone R, Shoenfeld Y (2013) Smell and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol 45:87–96
Perricone C, Agmon-Levin N, Shoenfeld N, de Carolis C, Guarino MD, Gigliucci G et al (2011) Evidence of impaired sense of smell in hereditary angioedema. Allergy 66:149–201
Tektonidou MG, Serelis J, Skopouli FN (2007) Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment. Clin Rheumatol 26:258–260
Stanbury RM, Graham EM (1998) Systemic corticosteroid therapy—side effects and their management. Br J Ophthalmol 82:704–719
Malaty J, Malaty IA (2013) Smell and taste disorders in primary care. Am Fam Physician 88:852–888
Hyphantis T, Kotsis K, Tsifetaki N, Creed F, Drosos AA, Carvalho AF et al (2013) The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis. Clin Rheumatol 32:635–644
Croy I, Symmank A, Schellong J, Hummel C, Gerber J, Joraschky P et al (2014) Olfaction as a marker for depression in humans. J Affect Disord 160:80–86
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yalcinkaya, E., Basaran, M.M., Erdem, H. et al. Olfactory dysfunction in spondyloarthritis. Eur Arch Otorhinolaryngol 276, 1241–1245 (2019). https://doi.org/10.1007/s00405-019-05364-1